WS #10069

23:44→00:12 UTC

From 495 msgs · 5 key-dev

Biogen agrees to acquire RayThera for up to $1B, adding immunology assets including a Phase 1-ready candidate.

Biogen Acquires RayThera

Biogen agrees to acquire RayThera for up to $1B, adding immunology assets including a Phase 1-ready candidate.